Rowe Jeffrey M 4
4 · Zomedica Pharmaceuticals Corp. · Filed Dec 3, 2018
Insider Transaction Report
Form 4
Rowe Jeffrey M
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2018-11-29−175,000→ 0 totalExercise: $1.20From: 2016-12-21Exp: 2018-12-21→ Common Shares, without par value (175,000 underlying) - Exercise/Conversion
Common Shares, without par value
2018-11-29$1.20/sh+175,000$210,000→ 275,000 total
Holdings
- 664,480(indirect: By Trust)
Common Shares, without par value
- 11,120,000(indirect: By Trust)
Common Shares, without par value
- 181,000(indirect: By IRA)
Common Shares, without par value
Footnotes (3)
- [F1]The reporting person serves as Trustee. Reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
- [F2]Reporting person's sister serves as trustee with reporting person's oversight. Reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or any other purpose.
- [F3]The options vested upon grant. The option is currently fully vested.